Careers

“After finishing my PhD, I was looking for a biotech company that develops smart and modular antibody-based therapies for cancer patients within a novel immunotherapeutic field. LAVA combines exactly these two facets by using its Gammabody™ platform to engage gamma delta T cells, a relatively novel and promising player in the immunotherapy game. I joined LAVA not only because of its solid scientific foundations, but also because it is a young and rapidly growing company that allows me to learn a lot along its development and broaden my horizon as a scientist and professional. As the icing on the cake, LAVA’s international group of colleagues creates a pleasant and fun atmosphere resulting an overall excellent working experience.”

“I joined LAVA because of the amazing one-team culture. It is evident that LAVA is focused on building successful and healthy teams, to achieve our main purpose of transforming the lives of the people with cancer. We get the opportunity to grow and develop our skills. I feel like I can give the best of myself and be the best version of myself! It has been a great experience, with an excellent and fun atmosphere!”

“Lava Therapeutics is a very innovative working environment, with dedicated, supportive colleagues, all of us working towards a singular purpose – to improve lives of cancer patients! Every day at Lava is motivating, filled with new learnings, and innovation on the cutting edge of immuno-oncology science.”

“I recently joined LAVA therapeutics and the first thing I have noticed is the great atmosphere of the company. Our team consists of different disciplines with a wide range of skill set. Everyone is excited and eager to work on the development of Gammabodies. In this short period of time, I was exposed to the collective collaboration and the interchange of knowledge from different departments. Seeing the overall process of the development of our therapeutic compounds makes our work very insightful. Overall, it is a great place to work and I am very excited to be part of the company.”